Literature DB >> 23081731

Temporal trend of overall survival in patients with advanced non-small cell lung cancer given first-line cytotoxic treatments.

Andrea Messori, Dario Maratea, Valeria Fadda, Sabrina Trippoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23081731     DOI： 10.1007/s00408-012-9426-4

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  10 in total

1.  How should meta-regression analyses be undertaken and interpreted?

Authors:  Simon G Thompson; Julian P T Higgins
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.

Authors:  Fabiola Del Santo; Dario Maratea; Valeria Fadda; Sabrina Trippoli; Andrea Messori
Journal:  Eur J Clin Pharmacol       Date:  2011-11-05       Impact factor: 2.953

Review 3.  Immediate and late outcome of patients aged 80 years and older undergoing isolated aortic valve replacement: a systematic review and meta-analysis of 48 studies.

Authors:  Francesco Vasques; Andrea Messori; Ersilia Lucenteforte; Fausto Biancari
Journal:  Am Heart J       Date:  2012-03       Impact factor: 4.749

4.  Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.

Authors:  Elisabeth Quoix; Gérard Zalcman; Jean-Philippe Oster; Virginie Westeel; Eric Pichon; Armelle Lavolé; Jérôme Dauba; Didier Debieuvre; Pierre-Jean Souquet; Laurence Bigay-Game; Eric Dansin; Michel Poudenx; Olivier Molinier; Fabien Vaylet; Denis Moro-Sibilot; Dominique Herman; Jaafar Bennouna; Jean Tredaniel; Alain Ducoloné; Marie-Paule Lebitasy; Laurence Baudrin; Silvy Laporte; Bernard Milleron
Journal:  Lancet       Date:  2011-08-08       Impact factor: 79.321

5.  Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis.

Authors:  Gaetan Des Guetz; Bernard Uzzan; Patrick Nicolas; Dominique Valeyre; Georges Sebbane; Jean-François Morere
Journal:  Crit Rev Oncol Hematol       Date:  2012-04-23       Impact factor: 6.312

6.  Meta-analysis of observational studies to evaluate immediate outcomes after endarterectomy or stenting for carotid artery stenosis.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal:  Ann Vasc Surg       Date:  2012-11       Impact factor: 1.466

7.  Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials.

Authors:  Federica Cuppone; Emilio Bria; Vanja Vaccaro; Fabio Puglisi; Alessandra Fabi; Isabella Sperduti; Paolo Carlini; Michele Milella; Cecilia Nisticò; Michelangelo Russillo; Paola Papaldo; Gianluigi Ferretti; Matti Aapro; Diana Giannarelli; Francesco Cognetti
Journal:  J Exp Clin Cancer Res       Date:  2011-05-12

8.  Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression.

Authors:  Hu Fulan; Jiang Changxing; Wang Yi Baina; Zhang Wencui; Lin Chunqing; Wang Fan; Li Dandan; Sun Dianjun; Wang Tong; Pang Da; Zhao Yashuang
Journal:  Cancer Causes Control       Date:  2011-07-15       Impact factor: 2.506

Review 9.  Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression.

Authors:  Giuseppe G L Biondi-Zoccai; Antonio Abbate; Pierfrancesco Agostoni; Luca Testa; Francesco Burzotta; Marzia Lotrionte; Carlo Trani; Luigi M Biasucci
Journal:  Am Heart J       Date:  2005-03       Impact factor: 4.749

Review 10.  Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Authors:  Wei-Xiang Qi; Li-na Tang; Ai-na He; Zan Shen; Feng Lin; Yang Yao
Journal:  Lung       Date:  2012-06-19       Impact factor: 2.584
  10 in total
  1 in total

1.  Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012.

Authors:  Andrea Messori; Margherita Conti; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal:  World J Clin Oncol       Date:  2014-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.